CVS Stock Ownership Activity

CVS HEALTH CORP 13F holders

4 value investing gurus have made changes to the CVS HEALTH CORP (CVS) position according to the gurus' latest SEC quarterly report(s). CVS has been completely sold out by 1 guru(s), the number of CVS shares has been increased by 3 super investor(s).

Which gurus or hedge funds are buying CVS now?

According to the latest SEC filing(s) CVS HEALTH CORP (CVS) has been bought by 3 gurus: V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (added shares +34.59%), Robert Olstein - Olstein Capital Management (added shares +20.16%) and Andrew Brenton - Turtle Creek Asset Management (added shares +0.92%).

To see more about who is investing in CVS HEALTH CORP (CVS), please go to the CVS ownership page.

2024 Q2 (1 result)
Robert Olstein
+20.16%
+26,000
+0.27%
1.63%
Current price: $59.00 0.10% Reported price*: $59.06
2024 Q1 (4 results)
Michael Burry
-100.00%
-65,000
-4.96%
0.00%
V. D. Dodge, E. M. Cox
+34.59%
+7,078,900
+0.52%
2.03%
Robert Olstein
-9.15%
-13,000
-0.17%
1.68%
Andrew Brenton
+0.92%
+15,666
+0.03%
3.34%
Current price: $59.00 26.03% AVG reported price*: $79.76
2023 Q4 (6 results)
Michael Burry
buy
+65,000
+5.43%
0.00%
Andrew Brenton
-6.84%
-116,203
-0.26%
3.30%
V. D. Dodge, E. M. Cox
+11.58%
+2,123,900
+0.17%
1.66%
Robert Olstein
-8.39%
-9,230
-0.17%
1.34%
David Katz
-2.50%
-500
-0.07%
2.55%
Bill Gates
-100.00%
-32,500
-0.01%
0.00%
Current price: $59.00 25.28% AVG reported price*: $78.96
2023 Q3 (7 results)
Michael Burry
-100.00%
-100,000
-15.75%
0.00%
Andrew Brenton
+3,527.71%
+1,776,200
+3.54%
3.64%
Ronald Muhlenkamp
-100.00%
-80,253
-2.64%
0.00%
V. D. Dodge, E. M. Cox
+71.03%
+6,512,962
+0.59%
1.20%
Mark A. Hillman
+26.15%
+17,000
+0.57%
2.74%
Robert Olstein
+12.32%
+17,000
+0.20%
1.86%
Bill Gates
buy
+32,500
+0.01%
0.00%
Current price: $59.00 15.50% AVG reported price*: $69.82
2023 Q2 (5 results)
Michael Burry
buy
+100,000
+6.21%
0.00%
Robert Olstein
+16.95%
+20,000
+0.22%
1.54%
V. D. Dodge, E. M. Cox
+19.17%
+1,725,100
+0.13%
0.81%
Andrew Brenton
+57.59%
+18,400
+0.04%
0.10%
Ronald Muhlenkamp
+0.52%
+414
+0.01%
0.00%
Current price: $59.00 14.65% AVG reported price*: $69.13
2023 Q1 (2 results)
Robert Olstein
+51.28%
+40,000
+0.47%
1.37%
Andrew Brenton
+486.24%
+26,500
+0.06%
0.07%
Current price: $59.00 20.60% AVG reported price*: $74.31
2022 Q4 (4 results)
Robert Olstein
+2.63%
+2,000
+0.03%
1.14%
V. D. Dodge, E. M. Cox
-2.19%
-201,200
-0.02%
0.97%
Andrew Brenton
+289.29%
+3,604
+0.01%
0.02%
Ronald Muhlenkamp
+0.11%
+122
+0.00%
4.35%
Current price: $59.00 36.69% AVG reported price*: $93.19
2022 Q3 (4 results)
David Katz
-15.97%
-3,800
-0.74%
3.92%
Ronald Muhlenkamp
+0.99%
+867
+0.05%
3.77%
Andrew Brenton
buy
+1,400
+0.01%
0.01%
V. D. Dodge, E. M. Cox
+0.19%
+17,000
+0.00%
1.13%
Current price: $59.00 38.19% AVG reported price*: $95.46
2022 Q2 (4 results)
Robert Olstein
-23.23%
-23,000
-0.32%
1.06%
Prem Watsa
-43.40%
-11,500
-0.04%
0.05%
V. D. Dodge, E. M. Cox
-1.32%
-122,700
-0.01%
1.02%
Ronald Muhlenkamp
-0.10%
-82
-0.00%
3.40%
Current price: $59.00 36.33% AVG reported price*: $92.66
2022 Q1 (4 results)
David Katz
-13.77%
-3,800
-0.58%
3.65%
Mark A. Hillman
-15.58%
-12,000
-0.49%
2.67%
Robert Olstein
-21.43%
-27,000
-0.34%
1.26%
Ronald Muhlenkamp
+0.37%
+298
+0.01%
2.84%
Current price: $59.00 41.71% AVG reported price*: $101.21
2021 Q4 (5 results)
Michael Burry
-100.00%
-200,000
-22.79%
0.00%
Robert Olstein
-28.81%
-51,000
-0.63%
1.55%
David Katz
-4.83%
-1,169
-0.21%
3.38%
V. D. Dodge, E. M. Cox
-4.43%
-431,000
-0.05%
1.00%
Ronald Muhlenkamp
-0.01%
-12
-0.00%
3.91%
Current price: $59.00 42.81% AVG reported price*: $103.16
2021 Q3 (2 results)
Robert Olstein
-1.67%
-3,000
-0.03%
1.84%
Ronald Muhlenkamp
-0.17%
-189
-0.01%
3.54%
Current price: $59.00 30.47% AVG reported price*: $84.86
48 of 144

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.